Key result
Extracellular vesicles are involved in COPD pathogenesis and have potential clinical usefulness as biomarkers and therapeutic agents for the treatment of COPD.
Answers are grounded in this paper and cite their sources.
Extracellular vesicles are involved in COPD pathogenesis and may serve as novel biomarkers and therapeutic agents.
Chronic obstructive pulmonary disease (COPD) is characterized by the progression of irreversible airflow limitation and is a leading cause of morbidity and mortality worldwide. Although several crucial mechanisms of COPD pathogenesis have been studied, the precise mechanism remains unknown. Extracellular vesicles (EVs), including exosomes, microvesicles, and apoptotic bodies, are released from almost all cell types and are recognized as novel cell-cell communication tools. They have been shown to carry and transfer a wide variety of molecules, such as microRNAs, messenger RNAs, and proteins, which are involved in physiological functions and the pathology of various diseases. Recently, EVs have attracted considerable attention in pulmonary research. In this review, we summarize the recent findings of EV-mediated COPD pathogenesis. We also discuss the potential clinical usefulness of EVs as biomarkers and therapeutic agents for the treatment of COPD.
No takes yet. Share an insight, caveat, or question.
Kadota et al. (2016) conducted a review in Chronic obstructive pulmonary disease (COPD). Extracellular vesicles was evaluated. Extracellular vesicles are involved in COPD pathogenesis and have potential clinical usefulness as biomarkers and therapeutic agents for the treatment of COPD.
Synapse has enriched 10 related papers. Consider them for comparative context: